A citation-based method for searching scientific literature

Irene Catucci, Silvia Casadei, Yuan Chun Ding, Sara Volorio, Filomena Ficarazzi, Anna Falanga, Marina Marchetti, Carlo Tondini, Michela Franchi, Aaron Adamson, Jessica Mandell, Tom Walsh, Olufunmilayo I Olopade, Siranoush Manoukian, Paolo Radice, Charite Ricker, Jeffrey Weitzel, Mary-Claire King, Paolo Peterlongo, Susan L Neuhausen. Breast Cancer Res Treat 2016
Times Cited: 6







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
347
50

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
111
33

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
520
33

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.
J Abugattas, M Llacuachaqui, Y Sullcahuaman Allende, A Arias Velásquez, R Velarde, J Cotrina, M Garcés, M León, G Calderón, M de la Cruz,[...]. Clin Genet 2015
39
33

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson, Jeffrey N Weitzel, Steven A Narod. Gynecol Oncol 2012
47
33

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
158
33

Progress and remaining challenges for cancer control in Latin America and the Caribbean.
Kathrin Strasser-Weippl, Yanin Chavarri-Guerra, Cynthia Villarreal-Garza, Brittany L Bychkovsky, Marcio Debiasi, Pedro E R Liedke, Enrique Soto-Perez-de-Celis, Don Dizon, Eduardo Cazap, Gilberto de Lima Lopes,[...]. Lancet Oncol 2015
99
33

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
C Villarreal-Garza, J N Weitzel, M Llacuachaqui, E Sifuentes, M C Magallanes-Hoyos, L Gallardo, R M Alvarez-Gómez, J Herzog, D Castillo, R Royer,[...]. Breast Cancer Res Treat 2015
48
33

Clinical significance of large rearrangements in BRCA1 and BRCA2.
Thaddeus Judkins, Eric Rosenthal, Christopher Arnell, Lynn Anne Burbidge, Wade Geary, Toby Barrus, Jeremy Schoenberger, Jeffrey Trost, Richard J Wenstrup, Benjamin B Roa. Cancer 2012
89
33

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Cynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, Luis A Herrera, Josef Herzog, Danielle Castillo, Alejandro Mohar, Clementina Castro, Lenny N Gallardo, Dolores Gallardo,[...]. Cancer 2015
63
33

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
559
33

Characterization of an Italian founder mutation in the RING-finger domain of BRCA1.
Laura Caleca, Anna Laura Putignano, Mara Colombo, Caterina Congregati, Mohosin Sarkar, Thomas J Magliery, Carla B Ripamonti, Claudia Foglia, Bernard Peissel, Daniela Zaffaroni,[...]. PLoS One 2014
18
33

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo.
Irene Catucci, Paolo Peterlongo, Sara Ciceri, Mara Colombo, Graziella Pasquini, Monica Barile, Bernardo Bonanni, Paolo Verderio, Sara Pizzamiglio, Claudia Foglia,[...]. Genet Med 2014
22
33

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
82
33


Admixture in Latin America.
Kaustubh Adhikari, Javier Mendoza-Revilla, Juan Camilo Chacón-Duque, Macarena Fuentes-Guajardo, Andrés Ruiz-Linares. Curr Opin Genet Dev 2016
45
16

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
47
16

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Magda C B Gomes, Mauricio M Costa, Radovan Borojevic, Alvaro N A Monteiro, Roberto Vieira, Sergio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang,[...]. Breast Cancer Res Treat 2007
57
16

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Talia Donenberg, John Lunn, Duvaughn Curling, Theodore Turnquest, Elisa Krill-Jackson, Robert Royer, Steven A Narod, Judith Hurley. Breast Cancer Res Treat 2011
57
16

BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.
Angela Rosaria Solano, Gitana Maria Aceto, Dreanina Delettieres, Serena Veschi, Maria Isabel Neuman, Eduardo Alonso, Sergio Chialina, Reinaldo Daniel Chacón, Mariani-Costantini Renato, Ernesto Jorge Podestá. Springerplus 2012
37
16

Medical genetics and genetic counseling in Chile.
Sonia B Margarit, Mónica Alvarado, Karin Alvarez, Guillermo Lay-Son. J Genet Couns 2013
11
16

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
548
16

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
16

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.
Edenir Inêz Palmero, Bárbara Alemar, Lavínia Schüler-Faccini, Pierre Hainaut, Carlos Alberto Moreira-Filho, Ingrid Petroni Ewald, Patricia Koehler Dos Santos, Patricia Lisbôa Izetti Ribeiro, Cristina Brinkmann de Netto Oliveira, Florence Le Calvez-Kelm,[...]. Genet Mol Biol 2016
11
16

Outcomes from intensive training in genetic cancer risk counseling for clinicians.
Kathleen R Blazer, Deborah J MacDonald, Charite Ricker, Sharon Sand, Gwen C Uman, Jeffrey N Weitzel. Genet Med 2005
26
16

Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals.
Andrés Ruiz-Linares, Kaustubh Adhikari, Victor Acuña-Alonzo, Mirsha Quinto-Sanchez, Claudia Jaramillo, William Arias, Macarena Fuentes, María Pizarro, Paola Everardo, Francisco de Avila,[...]. PLoS Genet 2014
248
16

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.
Gabriela Es Felix, Camila Abe-Sandes, Taísa Mb Machado-Lopes, Thaís F Bomfim, Rodrigo Santa Cruz Guindalini, Vanessa Catarine Sar Santos, Lorena Meyer, Polyanna C Oliveira, João Cláudio Neiva, Roberto Meyer,[...]. Hum Genome Var 2014
33
16

Breast cancer in young women in Latin America: an unmet, growing burden.
Cynthia Villarreal-Garza, Christian Aguila, Maria C Magallanes-Hoyos, Alejandro Mohar, Enrique Bargalló, Abelardo Meneses, Eduardo Cazap, Henry Gomez, Lizbeth López-Carrillo, Yanin Chávarri-Guerra,[...]. Oncologist 2013
48
16

[Genetic counseling about cancer in Peru].
Javier E Manrique, Yasser Sullcahuamán-Allende, Abel Limache-García. Rev Peru Med Exp Salud Publica 2013
3
33

Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography.
Daniel S W Tan, Tony S K Mok, Timothy R Rebbeck. J Clin Oncol 2016
109
16

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.
V F Esteves, L C S Thuler, L C Amêndola, R J Koifman, S Koifman, P P Frankel, R J S Vieira. Braz J Med Biol Res 2009
19
16

Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.
Julie Dutil, Jose L Colon-Colon, Jaime L Matta, Rebecca Sutphen, Miguel Echenique. Cancer Genet 2012
23
16

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice.
Angela Rosaria Solano, Florencia Cecilia Cardoso, Vanesa Romano, Florencia Perazzo, Carlos Bas, Gonzalo Recondo, Francisco Bernardo Santillan, Eduardo Gonzalez, Eduardo Abalo, María Viniegra,[...]. Oncotarget 2016
21
16

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.
Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Mauricio Lema, Robert Royer, Song Li, Garrett Larson, Jeffrey N Weitzel,[...]. Hered Cancer Clin Pract 2014
32
16

Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.
Laura Fejerman, Gary K Chen, Celeste Eng, Scott Huntsman, Donglei Hu, Amy Williams, Bogdan Pasaniuc, Esther M John, Marc Via, Christopher Gignoux,[...]. Hum Mol Genet 2012
48
16

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
L Delgado, G Fernández, G Grotiuz, S Cataldi, A González, N Lluveras, M Heguaburu, R Fresco, D Lens, G Sabini,[...]. Breast Cancer Res Treat 2011
17
16

BRCA1 and BRCA2: 1994 and beyond.
Steven A Narod, William D Foulkes. Nat Rev Cancer 2004
619
16

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba.
Rolando Comacho Rodriguez, Antonio Alejandro Esperon, Ramon Ropero, Maria Caridad Rubio, Ronald Rodriguez, Rosa M Ortiz, Juan J Lence Anta, Mario de los Rios, Deyanira Carnesolta, Maria C del Olivera,[...]. Fam Cancer 2008
28
16

The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.
A Vega, B Campos, B Bressac-De-Paillerets, P M Bond, N Janin, F S Douglas, M Domènech, M Baena, C Pericay, C Alonso,[...]. Hum Mutat 2001
77
16

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families.
Patricio Gonzalez-Hormazabal, Sara Gutierrez-Enriquez, Daniel Gaete, Jose M Reyes, Octavio Peralta, Enrique Waugh, Fernando Gomez, Sonia Margarit, Teresa Bravo, Rafael Blanco,[...]. Breast Cancer Res Treat 2011
35
16

High cancer drug prices in the United States: reasons and proposed solutions.
Hagop Kantarjian, David Steensma, Judit Rius Sanjuan, Adam Elshaug, Donald Light. J Oncol Pract 2014
75
16

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Julie Dutil, Volha A Golubeva, Alba L Pacheco-Torres, Hector J Diaz-Zabala, Jaime L Matta, Alvaro N Monteiro. Breast Cancer Res Treat 2015
56
16

BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.
Pablo Ruiz-Flores, Olga M Sinilnikova, Michael Badzioch, A L Calderon-Garcidueñas, Sandrine Chopin, Odefrey Fabrice, J F González-Guerrero, Csilla Szabo, Gilbert Lenoir, David E Goldgar,[...]. Hum Mutat 2002
34
16

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Marcela Gallardo, Antonia Silva, Lorena Rubio, Carolina Alvarez, Carolina Torrealba, Mauricio Salinas, Teresa Tapia, Paola Faundez, Lorena Palma, María Eugenia Riccio,[...]. Breast Cancer Res Treat 2006
52
16

Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
Sonia Garritano, Federica Gemignani, Edenir Inez Palmero, Magali Olivier, Ghyslaine Martel-Planche, Florence Le Calvez-Kelm, Laurence Brugiéres, Fernando Regla Vargas, Ricardo Renzo Brentani, Patricia Ashton-Prolla,[...]. Hum Mutat 2010
92
16

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
16

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
Felipe Vaca-Paniagua, Rosa María Alvarez-Gomez, Verónica Fragoso-Ontiveros, Silvia Vidal-Millan, Luis Alonso Herrera, David Cantú, Enrique Bargallo-Rocha, Alejandro Mohar, César López-Camarillo, Carlos Pérez-Plasencia. PLoS One 2012
32
16

Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin.
Catarina Santos, Ana Peixoto, Patrícia Rocha, Ana Vega, Maria José Soares, Nuno Cerveira, Susana Bizarro, Manuela Pinheiro, Deolinda Pereira, Helena Rodrigues,[...]. Fam Cancer 2009
8
16

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.
Patricia Ashton-Prolla, Fernando Regla Vargas. Genet Mol Biol 2014
24
16

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.
Simone Maistro, Natalia Teixeira, Giselly Encinas, Maria Lucia Hirata Katayama, Vivian Dionisio Tavares Niewiadonski, Larissa Garcia Cabral, Roberto Marques Ribeiro, Nelson Gaburo Junior, Ana Carolina Ribeiro Chaves de Gouvêa, Dirce Maria Carraro,[...]. BMC Cancer 2016
33
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.